Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents

Area of Science:

• Radiochemistry
• Neuroscience
• Pharmacology

Background:

• Serotonin 5-HT(1A) receptors are crucial in regulating mood and cognition.
• Developing selective radiotracers for these receptors is vital for neuroimaging.

Purpose of the Study:

• To synthesize and evaluate novel technetium-99m (99mTc) complexes as potential imaging agents for serotonin 5-HT(1A) receptors.
• To assess the in vitro binding affinity and in vivo brain uptake of these 99mTc complexes.

Main Methods:

• Synthesis of 99mTcO[SN(R)S][S] complexes featuring a 1-(2-methoxyphenyl)piperazine moiety.
• Preparation of analogous oxorhenium complexes for structural characterization and in vitro binding assays.
• Competition binding tests in rat hippocampal preparations and biodistribution studies in rats.

Main Results:

• Oxorhenium analogues exhibited nanomolar affinity for 5-HT(1A) receptor binding sites (IC(50) = 5.8-103 nM).
• All 99mTc complexes demonstrated significant brain uptake in rats within 2 minutes post-injection (0.24-1.31% ID).
• A direct correlation between brain radioactivity distribution and 5-HT(1A) receptor distribution was not observed.

Conclusions:

• The synthesized 99mTc complexes possess affinity for 5-HT(1A) receptors and exhibit brain penetration.
• Further optimization is required to achieve selective targeting and accurate mapping of 5-HT(1A) receptor distribution in vivo.